Conventional implants were used by orthopedic surgeons to fix the internal fixation for years. These implants have required a lot of development over the decades. These bioresorbable implants dissolve in the human body and then get replaced by the natural bones. The implants are large, interconnecting porous assembly is needed so that it can be integrated with the implant for better vascularization. By the additive manufacturing technology, this interconnecting porous structure can be manufactured directly. Rising incidences of chronic diseases, increasing geriatric population, growing incidences of road accidents, rising disposable incomes and high level of healthcare are expected to fuel the growth of the market during the forecast period. Moreover, growing healthcare market in emerging economies is offering opportunities for the market growth.
The "Global Bioresorbable Implants Market Analysis to 2031" is a specialized and in-depth study of the medical device industry with a focus on the global market trend. The report aims to provide an overview of global market with detailed market segmentation by product, application and geography. The global bioresorbable implants market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Bioresorbable Implants market players and offers key trends and opportunities in the market.
The global Bioresorbable Implants market is segmented on the basis of product and application. Based on product, the market is segmented as, PGA (polyglycolic acid), PLA (polylactic acid), PDS (polydioxanone), and Self-reinforcing (SR). The bioresorbable implants market is categorized based on application such as, pediatric orthopaedics, osteomyelitis and others.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global bioresorbable implants market based on product and application. It also provides market size and forecast till 2031 for overall market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Bioresorbable Implants market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 countries globally along with current trend and opportunities prevailing in the region.
North America is expected to contribute to the largest share in the bioresorbable implants market in the coming years, owing to rising demand of bioresorbable implants owing to the increasing incidences of orthopedic and dental ailments, and high adoption rate of bioresorbable implants in this region. Asia Pacific is expected to witness significant growth rate in the bioresorbable implants market during the forecast period, due to extensive awareness about the bioresorbable implants, these areas are most likely to be potential markets for bioresorbable implant in the region.
The report analyzes factors affecting bioresorbable implants market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the bioresorbable implants market in these regions.
The report also includes the profiles of key bioresorbable implants companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years. Some of the key players operating in the bioresorbable implants market include, Bioretec Ltd., Depuy Synthes, Stryker, Smith & Nephew, Zimmer Biomet, Medtronic, Nuvasive, Inc., BRI.TECH GMBH, OSSIO, and Reva Medical, Inc. among others. REGIONAL FRAMEWORK
MARKET PLAYERS
The "Global Bioresorbable Implants Market Analysis to 2031" is a specialized and in-depth study of the medical device industry with a focus on the global market trend. The report aims to provide an overview of global market with detailed market segmentation by product, application and geography. The global bioresorbable implants market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Bioresorbable Implants market players and offers key trends and opportunities in the market.
The global Bioresorbable Implants market is segmented on the basis of product and application. Based on product, the market is segmented as, PGA (polyglycolic acid), PLA (polylactic acid), PDS (polydioxanone), and Self-reinforcing (SR). The bioresorbable implants market is categorized based on application such as, pediatric orthopaedics, osteomyelitis and others.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global bioresorbable implants market based on product and application. It also provides market size and forecast till 2031 for overall market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Bioresorbable Implants market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 countries globally along with current trend and opportunities prevailing in the region.
North America is expected to contribute to the largest share in the bioresorbable implants market in the coming years, owing to rising demand of bioresorbable implants owing to the increasing incidences of orthopedic and dental ailments, and high adoption rate of bioresorbable implants in this region. Asia Pacific is expected to witness significant growth rate in the bioresorbable implants market during the forecast period, due to extensive awareness about the bioresorbable implants, these areas are most likely to be potential markets for bioresorbable implant in the region.
The report analyzes factors affecting bioresorbable implants market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the bioresorbable implants market in these regions.
The report also includes the profiles of key bioresorbable implants companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years. Some of the key players operating in the bioresorbable implants market include, Bioretec Ltd., Depuy Synthes, Stryker, Smith & Nephew, Zimmer Biomet, Medtronic, Nuvasive, Inc., BRI.TECH GMBH, OSSIO, and Reva Medical, Inc. among others. REGIONAL FRAMEWORK
Bioresorbable Implants Market Report Analysis
Bioresorbable Implants Market
-
CAGR (2023 - 2031)XX% -
Market Size 2023
US$ XX Million -
Market Size 2031
US$ XX Million
Report Coverage
- Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Key future trends
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Industry landscape and competition analysis & recent developments
- Detailed company profiles
- Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
Key Players
- Bioretec Ltd.
- Depuy Synthes
- Stryker
- Smith & Nephew
- Zimmer Biomet
- Medtronic
- Nuvasive, Inc.
- BRI.TECH GMBH
- OSSIO
Regional Overview
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Market Segmentation
By Product
- PGA
- PLA
- PDS
- Self-Reinforcing
By Application
- Pediatric Orthopaedics
- Osteomyelitis
Bioresorbable Implants Market Report Scope
Report Attribute | Details |
---|---|
Market size in 2023 | US$ XX Million |
Market Size by 2031 | US$ XX Million |
Global CAGR (2023 - 2031) | XX% |
Historical Data | 2021-2022 |
Forecast period | 2024-2031 |
Segments Covered |
By Product
|
Regions and Countries Covered | North America
|
Market leaders and key company profiles |
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Trends and growth analysis reports related to Life Sciences : READ MORE..
The List of Companies
1. Bioretec Ltd.
2. Depuy Synthes
3. Stryker
4. Smith & Nephew
5. Zimmer Biomet
6. Medtronic
7. Nuvasive, Inc.
8. BRI.TECH GMBH
9. OSSIO
10. Reva Medical, Inc.
1. Bioretec Ltd.
2. Depuy Synthes
3. Stryker
4. Smith & Nephew
5. Zimmer Biomet
6. Medtronic
7. Nuvasive, Inc.
8. BRI.TECH GMBH
9. OSSIO
10. Reva Medical, Inc.